Drug
3% Diquafosol tetrasodium
3% Diquafosol tetrasodium is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Completed1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed125%
not_yet_recruiting125%
unknown250%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye
NCT05682547
not_yet_recruitingnot_applicable
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT06537349
unknownnot_applicable
Diquafosol Ophthalmic Solution for Dry Eye Symptoms
NCT04980144
unknownnot_applicable
Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye
NCT05193331
Clinical Trials (4)
Showing 4 of 4 trials
NCT05682547Not Applicable
Diquafosol vs Hyaluronic Acid for Diabetic Dry Eye
NCT06537349Not Applicable
Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye
NCT04980144Not Applicable
Diquafosol Ophthalmic Solution for Dry Eye Symptoms
NCT05193331Not Applicable
Use of 3% Diquafosol Topical Ophthalmic Solution for Diabetic Dry Eye
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4